Back to search

Peptide record

TPDB06920

BmKn2 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06920
BmKn2
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 dbACP Antifungipept dbAMP 3.0 AI4AVP DRAVP 2.0 APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FIGAIARLLSKIF
Physicochemical Analysis
C71H117N17O15
NDCEQHMPTWYV
I
1448.81
11.49
2
0
9
+2
-2.71
1.592
165.38
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
1
Residue Composition
number
2
A
1
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
3
I
2
L
1
K
0
M
2
F
0
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 3 L: 2 K: 1 M: 0 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
13
C71H117N17O15
1448.81
11.49
+2
-2.71
1.592
Free
L
Linear
Free
Antimicrobial
Mesobuthus martensii Karsch
Evidence Records 45 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.6 µg/mL

Target

Staphylococcus aureus AB94004 or ATCC 25923 or MRSA P1386

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram+ bacteria S. aureus AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis
Evidence 2 Activity

Activity

MIC
Antibacterial
8.0 µg/mL

Target

M. luteus AB93113

Source & Reference

dbAMP DRAMP

Other

ive against Gram+ bacteria S. aureus AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epide
Evidence 3 Activity

Activity

MIC
Antibacterial
5.0 µg/mL

Target

B. subtilis AB91021

Source & Reference

dbAMP DRAMP

Other

s AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecal
Evidence 4 Activity

Activity

MIC
Antibacterial
12.5 µg/mL

Target

B. thuringiensis AB92037

Source & Reference

dbAMP DRAMP

Other

(MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml
Evidence 5 Activity

Activity

MIC
Antibacterial
2.5-5.0 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP

Other

0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 u
Evidence 6 Activity

Activity

MIC
Antibacterial
10 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP DRAMP

Other

.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066
Evidence 7 Activity

Activity

MIC
Antibacterial
10 µg/mL

Target

E. faecium

Source & Reference

dbAMP DRAMP

Other

AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21
Evidence 8 Activity

Activity

MIC
Antibacterial
1.5 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bacterici
Evidence 9 Activity

Activity

MIC
Antibacterial
21.3->100 µg/mL

Target

Pseudomonas aeruginosa AB93066 and 5 more strains

Source & Reference

dbAMP DRAMP

Other

ecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bactericidal activity against 18 clinical isolates of N. gonorrhoeae (MIC
Evidence 10 Activity

Activity

MIC50
Antibacterial
6.9-27.6 µM

Target

18 clinical isolates of N. gonorrhoeae

Source & Reference

dbAMP DRAMP

Other

66 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bactericidal activity against 18 clinical isolates of N. gonorrhoeae (MIC50 6.9-27.6 uM) ( Arpornsuwan et al., 2014 ) and 8 Salmonella clinical isolates ( Mangmee et al. 2021 ).
Evidence 11 Activity

Activity

IC50
IC50 = 29 µg/mL
Anticancer
29 µg/mL

Target

Tongue Squamous Cell Carcinoma
HSC-4
Tongue

Assay & Model

MTT assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2015

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 12 Activity

Activity

MIC
Antifungal
0.6 µg/mL

Target

Staphylococcus aureus AB94004 or ATCC 25923 or MRSA P1386

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram+ bacteria S. aureus AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis
Evidence 13 Activity

Activity

MIC
Antifungal
8.0 µg/mL

Target

M. luteus AB93113

Source & Reference

dbAMP DRAMP Antifungipept

Other

ive against Gram+ bacteria S. aureus AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epide
Evidence 14 Activity

Activity

MIC
Antifungal
5.0 µg/mL

Target

B. subtilis AB91021

Source & Reference

dbAMP DRAMP Antifungipept

Other

s AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecal
Evidence 15 Activity

Activity

MIC
Antifungal
12.5 µg/mL

Target

B. thuringiensis AB92037

Source & Reference

dbAMP DRAMP Antifungipept

Other

(MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml
Evidence 16 Activity

Activity

MIC
Antifungal
2.5-5.0 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP Antifungipept

Other

0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 u
Evidence 17 Activity

Activity

MIC
Antifungal
10 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP DRAMP Antifungipept

Other

.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066
Evidence 18 Activity

Activity

MIC
Antifungal
10 µg/mL

Target

E. faecium

Source & Reference

dbAMP DRAMP Antifungipept

Other

AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21
Evidence 19 Activity

Activity

MIC
Antifungal
1.5 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP Antifungipept

Other

MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bacterici
Evidence 20 Activity

Activity

MIC
Antifungal
21.3->100 µg/mL

Target

Pseudomonas aeruginosa AB93066 and 5 more strains

Source & Reference

dbAMP DRAMP Antifungipept

Other

ecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bactericidal activity against 18 clinical isolates of N. gonorrhoeae (MIC
Evidence 21 Activity

Activity

MIC50
Antifungal
6.9-27.6 µM

Target

18 clinical isolates of N. gonorrhoeae

Source & Reference

dbAMP DRAMP Antifungipept

Other

66 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bactericidal activity against 18 clinical isolates of N. gonorrhoeae (MIC50 6.9-27.6 uM) ( Arpornsuwan et al., 2014 ) and 8 Salmonella clinical isolates ( Mangmee et al. 2021 ).
Evidence 22 Activity

Activity

MIC
Antiparasitic
0.6 µg/mL

Target

Staphylococcus aureus AB94004 or ATCC 25923 or MRSA P1386

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against Gram+ bacteria S. aureus AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis
Evidence 23 Activity

Activity

MIC
Antiparasitic
8.0 µg/mL

Target

M. luteus AB93113

Source & Reference

dbAMP 3.0 DRAMP

Other

ive against Gram+ bacteria S. aureus AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epide
Evidence 24 Activity

Activity

MIC
Antiparasitic
5.0 µg/mL

Target

B. subtilis AB91021

Source & Reference

dbAMP 3.0 DRAMP

Other

s AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecal
Evidence 25 Activity

Activity

MIC
Antiparasitic
12.5 µg/mL

Target

B. thuringiensis AB92037

Source & Reference

dbAMP 3.0 DRAMP

Other

(MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml
Evidence 26 Activity

Activity

MIC
Antiparasitic
2.5-5.0 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP 3.0 DRAMP

Other

0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 u
Evidence 27 Activity

Activity

MIC
Antiparasitic
10 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP 3.0 DRAMP

Other

.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066
Evidence 28 Activity

Activity

MIC
Antiparasitic
10 µg/mL

Target

E. faecium

Source & Reference

dbAMP 3.0 DRAMP

Other

AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21
Evidence 29 Activity

Activity

MIC
Antiparasitic
1.5 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bacterici
Evidence 30 Activity

Activity

MIC
Antiparasitic
21.3->100 µg/mL

Target

Pseudomonas aeruginosa AB93066 and 5 more strains

Source & Reference

dbAMP 3.0 DRAMP

Other

ecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bactericidal activity against 18 clinical isolates of N. gonorrhoeae (MIC
Evidence 31 Activity

Activity

MIC50
Antiparasitic
6.9-27.6 µM

Target

18 clinical isolates of N. gonorrhoeae

Source & Reference

dbAMP 3.0 DRAMP

Other

66 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bactericidal activity against 18 clinical isolates of N. gonorrhoeae (MIC50 6.9-27.6 uM) ( Arpornsuwan et al., 2014 ) and 8 Salmonella clinical isolates ( Mangmee et al. 2021 ).
Evidence 32 Activity

Activity

MIC
Antiviral
0.6 µg/mL

Target

Staphylococcus aureus AB94004 or ATCC 25923 or MRSA P1386

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against Gram+ bacteria S. aureus AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis
Evidence 33 Activity

Activity

MIC
Antiviral
8.0 µg/mL

Target

M. luteus AB93113

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ive against Gram+ bacteria S. aureus AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epide
Evidence 34 Activity

Activity

MIC
Antiviral
5.0 µg/mL

Target

B. subtilis AB91021

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

s AB94004 or ATCC 25923 or MRSA P1386 (MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecal
Evidence 35 Activity

Activity

MIC
Antiviral
12.5 µg/mL

Target

B. thuringiensis AB92037

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

(MIC 0.6 ug/ml) M. luteus AB93113 (MIC 8.0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml
Evidence 36 Activity

Activity

MIC
Antiviral
2.5-5.0 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

0 ug/ml) B. subtilis AB91021 (MIC 5.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 u
Evidence 37 Activity

Activity

MIC
Antiviral
10 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

.0 ug/ml) B. thuringiensis AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066
Evidence 38 Activity

Activity

MIC
Antiviral
10 µg/mL

Target

E. faecium

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

AB92037 (MIC 12.5 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21
Evidence 39 Activity

Activity

MIC
Antiviral
1.5 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

MIC 2.5-5.0 ug/ml), E. faecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bacterici
Evidence 40 Activity

Activity

MIC
Antiviral
21.3->100 µg/mL

Target

Pseudomonas aeruginosa AB93066 and 5 more strains

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ecalis (MIC 10 ug/ml), E. faecium (MIC 10 ug/ml), Gram- bacteria E. coli (MIC 1.5 ug/ml), P. aeruginosa AB93066 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bactericidal activity against 18 clinical isolates of N. gonorrhoeae (MIC
Evidence 41 Activity

Activity

MIC50
Antiviral
6.9-27.6 µM

Target

18 clinical isolates of N. gonorrhoeae

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

66 and 5 more strains (MIC 21.3->100 ug/ml). It also showed bactericidal activity against 18 clinical isolates of N. gonorrhoeae (MIC50 6.9-27.6 uM) ( Arpornsuwan et al., 2014 ) and 8 Salmonella clinical isolates ( Mangmee et al. 2021 ).
Evidence 42 Activity

Activity

50% Hemolysis
Toxicity
17.13 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 17.13 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo. | PLoS One | 2012
Evidence 43 Activity

Activity

91.8% Hemolysis
Toxicity
25 µg/mL
Hemolytic Cytotoxic
91.8% Hemolysis | 25 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Fine-Tuning of Alkaline Residues on the Hydrophilic Face Provides a Non-toxic Cationic α-Helical Antimicrobial Peptide Against Antibiotic-Resistant ESKAPE Pathogens. | Front Microbiol | 2021
Evidence 44 Activity

Activity

0% Hemolysis
Toxicity
5.87 µM
Hemolytic Cytotoxic
0% Hemolysis | 5.87 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells | Int J Pept Res Ther | 2014
Evidence 45 Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.